Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Bankunited
BKU
$2.9B
| $5.6M | 0.01% |
153,700
-66,900
| -30% | -$2.44M |
|
1377
HarborOne Bancorp
HONE
$551M
| $5.6M | 0.01% |
431,141
+43,900
| +11% | +$570K |
|
1378
ZTO Express
ZTO
$15.5B
| $5.59M | 0.01% |
225,700
+58,400
| +35% | +$1.45M |
|
1379
Preferred Bank
PFBC
$1.17B
| $5.58M | 0.01% |
69,555
-4,800
| -6% | -$385K |
|
1380
Green Brick Partners
GRBK
$3.17B
| $5.58M | 0.01% |
66,809
+29,000
| +77% | +$2.42M |
|
1381
Diana Shipping
DSX
$214M
| $5.57M | 0.01% |
2,167,313
-878,271
| -29% | -$2.26M |
|
|
ESGR
1382
DELISTED
Enstar Group
ESGR
| $5.56M | 0.01% |
17,300
+14,400
| +497% | +$4.63M |
|
1383
Nurix Therapeutics
NRIX
$684M
| $5.54M | 0.01% |
246,400
-77,600
| -24% | -$1.74M |
|
1384
COPT Defense Properties
CDP
$3.45B
| $5.53M | 0.01% |
182,400
+84,100
| +86% | +$2.55M |
|
1385
CONMED
CNMD
$1.63B
| $5.51M | 0.01% |
+76,581
| New | +$5.51M |
|
1386
Barclays
BCS
$72.8B
| $5.48M | 0.01% |
450,900
-3,210,186
| -88% | -$39M |
|
|
ITOS
1387
DELISTED
iTeos Therapeutics
ITOS
| $5.48M | 0.01% |
536,400
-23,200
| -4% | -$237K |
|
1388
Riskified
RSKD
$715M
| $5.46M | 0.01% |
1,155,200
+36,300
| +3% | +$172K |
|
1389
Chemours
CC
$2.44B
| $5.46M | 0.01% |
268,900
+159,019
| +145% | +$3.23M |
|
1390
Fluor
FLR
$6.69B
| $5.45M | 0.01% |
114,200
+57,700
| +102% | +$2.75M |
|
1391
Goldman Sachs Physical Gold ETF Shares
AAAU
$1.77B
| $5.44M | 0.01% |
209,200
+143,100
| +216% | +$3.72M |
|
1392
Enanta Pharmaceuticals
ENTA
$178M
| $5.44M | 0.01% |
524,900
+14,000
| +3% | +$145K |
|
1393
LivaNova
LIVN
$3.13B
| $5.42M | 0.01% |
103,094
-49,300
| -32% | -$2.59M |
|
1394
Customers Bancorp
CUBI
$2.35B
| $5.41M | 0.01% |
116,520
+62,700
| +116% | +$2.91M |
|
1395
Fonar
FONR
$99.4M
| $5.4M | 0.01% |
333,516
-10,700
| -3% | -$173K |
|
1396
IDEAYA Biosciences
IDYA
$2.17B
| $5.4M | 0.01% |
170,365
+61,040
| +56% | +$1.93M |
|
1397
Forestar Group
FOR
$1.4B
| $5.39M | 0.01% |
166,480
+12,400
| +8% | +$401K |
|
1398
Immunovant
IMVT
$2.93B
| $5.39M | 0.01% |
189,000
-199,100
| -51% | -$5.68M |
|
1399
Northeast Community Bancorp
NECB
$272M
| $5.38M | 0.01% |
203,400
+56,012
| +38% | +$1.48M |
|
1400
TriMas Corp
TRS
$1.56B
| $5.38M | 0.01% |
210,700
+182,900
| +658% | +$4.67M |
|